REG - Surgical Innovations - Directorate Changes <Origin Href="QuoteRef">MDT.N</Origin> <Origin Href="QuoteRef">SUNU.L</Origin>
RNS Number : 1225USurgical Innovations Group PLC13 October 2014
13 October 2014
Surgical Innovations Group plc
("Surgical Innovations" or the "Company")
Directorate Changes
The Board of Surgical Innovations announces the appointment of Chris Rea as the Company's Interim Managing Directorwith immediate effect.
Mike Thornton continues as Finance Director and Company Secretary of Surgical Innovations and will also act as CEO of Surgical Innovations Ltd.
In line with an earlier Board decision to reduce the number of Directors given the current size of the Company, ColinGlass and Ray Simkinsstep down as Non-Executive Directors ofSurgical Innovations with immediate effect.
Doug Liversidge Chairman expressed on behalf of theBoard his sincerethanks to Colin and Ray for theirdedicated support of the Company overmany years.
Professor Mike McMahon remains a Non-Executive Director of Surgical Innovations and Clinical Advisorto the Company.
-Ends-
For further information please contact:
Surgical Innovations Group plc
Doug Liversidge CBE, Non-executive Chairman
Tel: 07798 892 918
Nominated Advisor and Broker
Panmure Gordon
Freddy Crossley / Peter Steel (Corporate Finance)
Tel: +44 (0) 207 886 2500
Media Enquiries
Abchurch Communications
Jamie Hopper / Stephanie Watson
Tel: +44 (0) 207 398 7700
This information is provided by RNSThe company news service from the London Stock ExchangeENDBOAEAEEDFAFLFFF
Recent news on Surgical Innovations
See all newsREG - Surgical Innovations - Holding(s) in Company
AnnouncementREG - Surgical Innovations - Holding(s) in Company
AnnouncementREG - Surgical Innovations - Final Results
AnnouncementREG - Surgical Innovations - New exclusive UK distribution agreements secured
AnnouncementREG - Surgical Innovations - Directorate Change & Notice of Results
Announcement